The best outcomes with GLP-1 medications come from people who use reduced appetite as an opportunity to build sustainable eating habits, not as a replacement for any attention to nutrition or activity
The study population included 240,618 patients with overweight or obesity who were prescribed semaglutide or non-GLP1R agonist anti-obesity medications, with the findings replicated in 1,589,855 patients with T2DM
Kindrew argues that the manufacturers' failure to disclose these risks contributed to her medical condition and suffering
A 40-week trial compared 5mg, 10mg and 15mg dosages of tirzepatide (which have all been approved for use) with 1mg of semaglutide
Shipping & Handling All orders are shipped with temperature-controlled packaging to preserve peptide integrity
The sensitivity analysis showed the same directionality and magnitude as the overall results when studies were excluded one by one (Supplementary Figure 3)